Procurement Summary
Country: Chile
Summary: Rituximab Supply Agreement at Puerto Hospital
Deadline: 22 May 2026
Posting Date: 23 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139991285
Document Ref. No.: 1058128-9-LR26
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Products or services: Drug or medicine production services The Puerto Montt Hospital requires hiring a supplier to supply the drug Rituximab, an essential biological medication for immunosuppressive and antineoplastic treatment. of patients with highly complex pathologies. This supply is intended for the care of adults and children with diagnoses that include, but are not limited to: Non-Hodgkin's Lymphomas and Chronic Lymphatic Leukemia. Rheumatoid Arthritis in patients with response unsuitable for other drugs. Serious autoimmune diseases, such as Granulomatosis with Polyangiitis and Microscopic Polyangiitis. All of the above in strict accordance with Exempt Resolution NO12, 499, issued on October 29, 2024, which approves the Therapeutic Arsenal of the Puerto Mont Hospital.
Documents
Tender Notice